FEMS microbiology letters | 2 Feb 2018
Emmanuelle Charpentier is a French microbiologist, geneticist and biochemist. She is a Director at the Max Planck Institute for Infection Biology in Berlin, Honorary Professor at Humboldt University, Visiting Professor at Umeå University and recipient of an Alexander von Humboldt Professorship. Prior to her current appointments, she worked at several other institutions in Germany, Sweden, Austria, the US and France. Emmanuelle Charpentier’s research on a bacterial immune system laid the foundation for the ground-breaking CRISPR-Cas9 genome engineering technology. She has received numerous prestigious awards and distinctions, and is an elected member of several renowned academies of sciences. She is co-founder of CRISPR Therapeutics and ERS Genomics.
* Data courtesy of Altmetric.com